Quince Therapeutics, Inc. (QNCX)
NASDAQ: QNCX · Real-Time Price · USD
3.590
+0.070 (1.99%)
At close: Dec 4, 2025, 4:00 PM EST
3.660
+0.070 (1.95%)
After-hours: Dec 4, 2025, 7:58 PM EST
Quince Therapeutics Market Cap
Quince Therapeutics has a market cap or net worth of $199.9 million as of December 4, 2025. Its market cap has increased by 155.22% in one year.
Market Cap
199.90M
Enterprise Value
191.60M
1-Year Change
155.22%
Ranking
Category
Stock Price
$3.59
Market Cap Chart
Since May 9, 2019, Quince Therapeutics's market cap has decreased from $855.58M to $199.90M, a decrease of -76.64%. That is a compound annual growth rate of -19.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 3, 2025 | 196.00M | 138.20% |
| Dec 31, 2024 | 82.28M | 82.80% |
| Dec 29, 2023 | 45.01M | 95.46% |
| Dec 30, 2022 | 23.03M | -93.89% |
| Dec 31, 2021 | 377.06M | -53.99% |
| Dec 31, 2020 | 819.45M | -45.64% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.36B |
| Johnson & Johnson | 487.83B |
| AbbVie | 404.22B |
| UnitedHealth Group | 302.09B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 250.41B |
| Abbott Laboratories | 218.05B |